Chronic Resveratrol Treatment Reduces the Pro-angiogenic Effect of Human Fibroblast "Senescent-Associated Secretory Phenotype" on Endothelial Colony-Forming Cells: The Role of IL8

J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):625-633. doi: 10.1093/gerona/gly175.

Abstract

Senescent cells are characterized by an increased secretion of inflammatory and growth factors, known as the "senescence-associated secretory phenotype" (SASP), producing a pro-tumoral and pro-angiogenic microenvironment. This work proposes chronic resveratrol treatment (5 µM for 5 weeks, termed R5) of senescent MRC5 fibroblasts as a mean to mimic and target the angiogenic trait of stromal fibroblast SASP. Senescent fibroblast conditioned medium (CM sen) was effective in enhancing the angiogenic properties of endothelial colony-forming cells (ECFCs), that is, invasive activity and capillary morphogenesis capability in vitro, that were significantly reduced when conditioned media were collected after resveratrol pretreatment (CM senR5). The attenuation of ECFC angiogenic phenotype induced by CM senR5 was accompanied by reduced protein levels of epidermal growth factor and urokinase plasminogen activator receptors (EGFR, uPAR), and by a related decreased activation of receptor-tyrosine-kinase signaling pathways. IL8 levels were found reduced in CM senR5 compared to CM sen, with the associated reduction of IL8-CXCR2 binding in ECFCs. IL8-subtraction mitigated the pro-angiogenic features of CM sen and the associated intracellular signaling in ECFCs, indicating a prominent role of IL8 in the pro-angiogenic effects of CM sen. IL8 modulation is an important mechanism underlying the antiangiogenic activity of resveratrol on MRC5 SASP.

Keywords: Cellular senescence; Endothelial cell; IL8; Microenvironment; Resveratrol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Surface / metabolism
  • Cells, Cultured
  • Cellular Senescence / drug effects*
  • Culture Media, Conditioned / pharmacology
  • Endothelial Cells / drug effects*
  • Epidermal Growth Factor / metabolism
  • ErbB Receptors / metabolism
  • Fibroblasts / drug effects*
  • Humans
  • Interleukin-8 / metabolism*
  • Neovascularization, Physiologic / drug effects*
  • Phenotype
  • Receptors, Urokinase Plasminogen Activator / metabolism
  • Resveratrol / pharmacology*
  • Signal Transduction

Substances

  • Antigens, Surface
  • Culture Media, Conditioned
  • Interleukin-8
  • Receptors, Urokinase Plasminogen Activator
  • Epidermal Growth Factor
  • ErbB Receptors
  • Resveratrol